Boston Scientific Corp.

Marlborough medical device manufacturer Boston Scientific Corp. has entered into an agreement to sell its BTG Specialty Pharmaceuticals business for $800 million in cash.

Marlborough medical device manufacturer Boston Scientific has voluntarily recalled the unused inventory of one of its aortic valve systems and announced it will discontinue the product.

Marlborough's Boston Scientific reported a slight $48-million quarterly loss on Wednesday, continuing a year of financial pain for the medical device company.

The two largest corporations Central Massachusetts corporations by market capitalization — Boston Scientific and TJX Cos. — did not do too well on a new review of how well companies match their actions with words to be more inclusive of society and less to shareholders.

Boston Scientific saw sales plunge by 24% in the second quarter, a loss of roughly $630 million from the same point a year ago in struggles the Marlborough medical device manufacturer foreshadowed with temporary work schedule reductions and executive pay cuts in the spring.

It’s been a worrying few months financially since the coronavirus pandemic hit in March – and that’s for those who’ve kept their job or their business in operation.

Boston Scientific said at the start of April it would temporarily reduce some employee work schedules and reduce executive and board pay, citing an expected effect of medical offices delaying elective surgeries. But the coronavirus pandemic hasn't hurt the Marlborough medical device maker's revenue, at least through the quarter ending March 31.

Boston Scientific Corp., the medical device manufacturer based in Marlborough, signed a virtual power purchase agreement with Clearway Energy Group of San Francisco, the company announced on Tuesday.

Boston Scientific is temporarily reducing some employee work schedules and reducing executive and board pay as the Marlborough medical device maker says it has been hurt by delays in elective surgeries during the coronavirus outbreak.

As recently as Feb. 19, stocks were riding high for Central Massachusetts-based public companies and beyond. As coronavirus has spread into a pandemic that's brought much of the economy to a standstill, those stocks have not been spared.